Molcure

Molcure, Inc. is a biopharmaceutical company based in Tokyo, Japan, specializing in the development of systems and technologies for antibody drug discovery. Founded in 2013, the company is focused on enhancing the therapeutic landscape by providing advanced solutions for pharmaceutical companies engaged in antibody drug development. Its primary offerings include Abtracer, an antibody sequence screening system that identifies effective antibody candidates, and SmartLabModule, an IoT platform designed to support scientific research. Molcure combines expertise in next-generation sequencing, bioinformatics, and antibody biology with automated discovery systems to deliver high-quality functional antibodies. The company’s innovative technology has been validated through various partnerships, and it actively seeks new collaboration opportunities to further advance its mission of improving patient outcomes through effective therapeutics.